Inhaled Amikacin Reduces Ventilatory-Associated Pneumonia

MONDAY, Oct. 30, 2023-- For critically ill patients undergoing mechanical ventilation for at least three days, a three-day course of inhaled amikacin reduces the subsequent burden of ventilatory-associated pneumonia, according to a study published...